Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Allen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1995
Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor geneC A Milano, L F Allen, P C Dolber, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2000
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusionJ G Supko, T J Lynch, J W Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2J W Lomasney, W Lorenz, L F Allen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1992
Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancerR F Meredith, M B Khazaeli, W E Plott, et al.
Science (New York, N.Y.)|April 22, 1994
Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptorC A Milano, L F Allen, H A Rockman, et al.
Journal of Radiotherapy in Practice|January 31, 2024
Head and neck radiotherapy quality assurance conference for dedicated review of delineated targets and organs at risk: results of a prospective studyJ C Farris, N B Razavian, M K Farris, et al.
Nature|March 16, 1995
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptorR A Bond, P Leff, T D Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignanciesM A Villalona-Calero, J P Eder, D L Toppmeyer, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1995
Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor geneC A Milano, L F Allen, P C Dolber, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2000
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusionJ G Supko, T J Lynch, J W Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2J W Lomasney, W Lorenz, L F Allen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1992
Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancerR F Meredith, M B Khazaeli, W E Plott, et al.
Science (New York, N.Y.)|April 22, 1994
Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptorC A Milano, L F Allen, H A Rockman, et al.
Journal of Radiotherapy in Practice|January 31, 2024
Head and neck radiotherapy quality assurance conference for dedicated review of delineated targets and organs at risk: results of a prospective studyJ C Farris, N B Razavian, M K Farris, et al.
Nature|March 16, 1995
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptorR A Bond, P Leff, T D Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignanciesM A Villalona-Calero, J P Eder, D L Toppmeyer, et al.
Pageof 2